Clinic
Christus Spohn Health System Corporation
Christus Spohn Health System Corporation was paid $10.46M by Medicaid between Mar 2019 and Nov 2024, across 88 billing codes. Its largest line is 99284, emergency room visit (serious) — 51% of everything it billed.
33Billing provider infoCHRISTUS SPOHN HEALTH SYSTEM CORPORATION
ALICE, TX 78332
ALICE, TX 78332
33aNPI1003885641assigned 03/16/2006
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$10.46M
24GClaims118,055
24DCodes billed88
24AFirst – last monthMar 2019 – Nov 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Rank by total paid#44 of 320
Median peer was paid$205K
This provider vs. median51×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 836 | $3K | |
| 2020 | 2,657 | $124K | |
| 2021 | 29,043 | $1.70M | |
| 2022 | 38,040 | $3.94M | |
| 2023 | 37,806 | $3.77M | |
| 2024incomplete | 9,673 | $926K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 51% | 6,776 | 6,359 | $5.33M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 28% | 11,006 | 10,527 | $2.91M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.0% | 1,510 | 1,409 | $631K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.4% | 1,351 | 1,316 | $254K |
| 71045 | Radiologic examination, chest; single view | 1.8% | 3,416 | 3,122 | $186K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.3% | 3,253 | 3,159 | $131K |
| 80053 | Comprehensive metabolic panel | 1.1% | 10,711 | 9,459 | $113K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.0% | 4,694 | 2,373 | $109K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,227 | 1,099 | $102K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 12,602 | 11,068 | $99K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,412 | 3,054 | $75K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 3,026 | 2,919 | $61K |
76 more codes
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 872 | $60K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,229 | $55K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 163 | $32K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,233 | $31K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 841 | $26K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 957 | $24K |
| 81001 | <1% | 5,505 | $19K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 91 | $17K |
| 83690 | <1% | 2,219 | $16K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 167 | $16K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 306 | $15K |
| 84484 | <1% | 2,815 | $9K | |
| 87070 | <1% | 639 | $9K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 372 | $9K |
| 80050 | General health panel | <1% | 56 | $8K |
| 86780 | <1% | 380 | $7K | |
| 86703 | <1% | 361 | $7K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 90 | $7K |
| 86328 | <1% | 378 | $6K | |
| 86803 | <1% | 298 | $6K | |
| 87340 | <1% | 360 | $5K | |
| 80061 | Lipid panel | <1% | 295 | $5K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 703 | $5K |
| 86850 | <1% | 71 | $4K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 494 | $4K |
| 87420 | <1% | 186 | $4K | |
| 81003 | <1% | 1,509 | $4K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 485 | $4K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 392 | $4K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 53 | $3K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,012 | $3K |
| 81025 | <1% | 221 | $3K | |
| 83880 | <1% | 624 | $3K | |
| 86738 | <1% | 100 | $2K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 39 | $2K |
| 84703 | <1% | 170 | $2K | |
| 84481 | <1% | 67 | $2K | |
| 82728 | <1% | 80 | $2K | |
| 82652 | <1% | 43 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,366 | $1K |
| 84466 | <1% | 69 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 251 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 139 | $1K |
| 82077 | <1% | 41 | $1K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 390 | $976.35 |
| 84439 | <1% | 70 | $949.88 | |
| 83540 | <1% | 94 | $925.10 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 927 | $902.95 |
| 83605 | <1% | 819 | $900.86 | |
| 83550 | <1% | 94 | $704.17 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 15,409 | $647.47 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 51 | $611.09 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 420 | $583.91 |
| 87040 | <1% | 475 | $512.03 | |
| 85730 | <1% | 872 | $511.58 | |
| 85610 | <1% | 1,281 | $504.56 | |
| 87081 | <1% | 45 | $439.38 | |
| 86901 | <1% | 141 | $386.84 | |
| 86900 | <1% | 142 | $386.84 | |
| 86317 | <1% | 16 | $319.88 | |
| 82607 | <1% | 13 | $292.10 | |
| 83735 | <1% | 229 | $223.51 | |
| 80320 | <1% | 12 | $175.60 | |
| 85027 | <1% | 203 | $123.16 | |
| 82950 | <1% | 12 | $119.52 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 144 | $63.58 |
| 82803 | <1% | 16 | $61.38 | |
| 82550 | <1% | 43 | $44.76 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 371 | $12.00 |
| 87186 | <1% | 14 | $10.19 | |
| A9270 | Non-covered item or service | 0% | 1,357 | $0.00 |
| 82962 | 0% | 1,257 | $0.00 | |
| 96376 | 0% | 12 | $0.00 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 372 | $0.00 |
| 36600 | 0% | 15 | $0.00 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBLOW, OSBERT (CEO)
| Provider | Location | Paid |
|---|---|---|
| Christus Spohn Health System Corporation | Corpus Christi, TX | $17.62M |
| Christus Spohn Health System Corporation | Beeville, TX | $6.22M |
| Christus Spohn Health System Corporation | Kingsville, TX | $5.93M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.